Published in JAMA on April 01, 1988
Pulmonary rehabilitation in chronic respiratory insufficiency. 6. Travel for technology-dependent patients with respiratory disease. Thorax (1994) 0.93
Air travel can be safe and well tolerated in patients with clinically stable pulmonary hypertension. Pulm Circ (2011) 0.75
Helping patients travel by air. CMAJ (1991) 0.75
Cardiovascular disease and airline travel. Heart (2007) 0.75
Case report: stroke following an airline flight. Can Fam Physician (2004) 0.75
In-flight deaths. JAMA (1989) 0.75
The pre-travel medical evaluation: the traveler with chronic illness and the geriatric traveler. Yale J Biol Med (1993) 0.75
Career prospects in cardiology in England and Wales. Survey and 15 health regions. Br Heart J (1981) 8.82
Survey of 3765 cardiopulmonary resuscitations in British hospitals (the BRESUS Study): methods and overall results. BMJ (1992) 6.82
Effects of atropine on heart-rate in healthy man. Lancet (1967) 5.10
Plasma digoxin concentrations in patients with atrial fibrillation. Br Med J (1970) 4.82
Metabolic function and properties of 4-hydroxyphenylacetic acid 1-hydroxylase from Pseudomonas acidovorans. J Bacteriol (1975) 4.69
Prehospital-initiated vs hospital-initiated thrombolytic therapy. The Myocardial Infarction Triage and Intervention Trial. JAMA (1993) 4.36
A community training scheme in cardiopulmonary resuscitation. Br Med J (Clin Res Ed) (1984) 3.83
Bacterial degradation of 4-hydroxyphenylacetic acid and homoprotocatechuic acid. J Bacteriol (1974) 3.70
Novel pathway of toluene catabolism in the trichloroethylene-degrading bacterium g4. Appl Environ Microbiol (1989) 3.53
Phenol and trichloroethylene degradation by Pseudomonas cepacia G4: kinetics and interactions between substrates. Appl Environ Microbiol (1990) 3.43
A milestone for myocardial infarction. BMJ (1988) 3.42
Stereospecific enzymes in the degradation of aromatic compounds by pseudomonas putida. J Bacteriol (1973) 3.33
The metabolism of beta-phenylpropionic acid by an Achromobacter. Biochem J (1965) 3.21
Catabolism of pseudocumene and 3-ethyltoluene by Pseudomonas putida (arvilla) mt-2: evidence for new functions of the TOL (pWWO) plasmid. J Bacteriol (1981) 3.16
The association between on-site cardiac catheterization facilities and the use of coronary angiography after acute myocardial infarction. Myocardial Infarction Triage and Intervention Project Investigators. N Engl J Med (1993) 3.12
Metabolism of resorcinylic compounds by bacteria: alternative pathways for resorcinol catabolism in Pseudomonas putida. J Bacteriol (1976) 3.08
The Brighton resuscitation ambulances: a continuing experiment in prehospital care by ambulance staff. Br Med J (1976) 2.66
Mobile coronary care provided by ambulance personnel. Br Med J (1973) 2.55
Isolation and characterization of a fluoranthene-utilizing strain of Pseudomonas paucimobilis. Appl Environ Microbiol (1990) 2.48
Hospital resuscitation from ventricular fibrillation in Brighton. Br Med J (1979) 2.43
Bacterial metabolism of naphthalene: construction and use of recombinant bacteria to study ring cleavage of 1,2-dihydroxynaphthalene and subsequent reactions. J Bacteriol (1992) 2.42
Frequency and types of medical emergencies among commercial air travelers. JAMA (1989) 2.35
Mouthguards and the role of sporting team dentists. Aust Dent J (1989) 2.33
Myocardial Infarction Triage and Intervention Project--phase I: patient characteristics and feasibility of prehospital initiation of thrombolytic therapy. J Am Coll Cardiol (1990) 2.32
Gentisic acid and its 3- and 4-methyl-substituted homologoues as intermediates in the bacterial degradation of m-cresol, 3,5-xylenol and 2,5-xylenol. Biochem J (1971) 2.26
Guidelines for Cardiopulmonary Resuscitation. Advanced life support. Revised recommendations of the Resuscitation Council (UK) BMJ (1989) 2.25
The Brighton resuscitation ambulances: review of 40 consecutive survivors of out-of-hospital cardiac arrest. Br Med J (1978) 2.24
The enzymic degradation of alkyl-substituted gentisates, maleates and malates. Biochem J (1971) 2.23
Reduction in hospital time to thrombolytic therapy by audit of policy guidelines. Eur Heart J (1990) 2.17
Purification and properties of gentisate 1,2-dioxygenase from Moraxella osloensis. J Bacteriol (1975) 2.15
Enzymic formation of D-malate. Biochem J (1968) 2.14
Automatic external defibrillators used by emergency medical technicians. A controlled clinical trial. JAMA (1987) 2.12
The bacterial metabolism of 2,4-xylenol. Biochem J (1968) 2.05
Metabolism of gallic acid and syringic acid by Pseudomonas putida. J Biol Chem (1972) 2.04
Purification and properties of 4-hydroxy-4-methyl-2-oxoglutarate aldolase. J Biol Chem (1972) 2.04
Ventricular arrhythmias caused by prenylamine. Br Med J (1977) 1.92
Oral mexiletine in high-risk patients after myocardial infarction. Lancet (1981) 1.91
Delay between onset of chest pain and seeking medical care: the effect of public education. Ann Emerg Med (1989) 1.88
Haemodynamic effects of salbutamol in patients with acute myocardial infarction and severe left ventricular dysfunction. Br Med J (1979) 1.82
Gender differences in the treatment and outcome of acute myocardial infarction. Results from the Myocardial Infarction Triage and Intervention Registry. Arch Intern Med (1992) 1.80
Anaerobic transformation of phenol to benzoate via para-carboxylation: use of fluorinated analogues to elucidate the mechanism of transformation. Biochem Biophys Res Commun (1989) 1.78
Cloning, physical mapping and expression of chromosomal genes specifying degradation of the herbicide 2,4,5-T by Pseudomonas cepacia AC1100. Gene (1988) 1.78
Survival of out-of-hospital cardiac arrest with early initiation of cardiopulmonary resuscitation. Am J Emerg Med (1985) 1.77
Orofacial injuries and the use of mouthguards by the 1984 Great Britain Rugby League touring team. Br J Sports Med (1985) 1.71
Five hundred patients with myocardial infarction monitored within one hour of symptoms. Br Med J (Clin Res Ed) (1983) 1.71
Catabolism of phenylpropionic acid and its 3-hydroxy derivative by Escherichia coli. J Bacteriol (1983) 1.68
Amiodarone increases plasma digoxin concentrations. Br Med J (Clin Res Ed) (1981) 1.61
Purification and properties of 4-hydroxy-2-ketopimelate aldolase from Acinetobacter. J Bacteriol (1974) 1.60
Action of a fluoranthene-utilizing bacterial community on polycyclic aromatic hydrocarbon components of creosote. Appl Environ Microbiol (1989) 1.58
Isolation and characterization of spontaneously occurring TOL plasmid mutants of Pseudomonas putida HS1. J Bacteriol (1981) 1.57
Actions of a versatile fluorene-degrading bacterial isolate on polycyclic aromatic compounds. Appl Environ Microbiol (1995) 1.55
Metabolism of resorcinylic compounds by bacteria: orcinol pathway in Pseudomonas putida. J Bacteriol (1976) 1.54
Biodegradation of creosote and pentachlorophenol in contaminated groundwater: chemical and biological assessment. Appl Environ Microbiol (1991) 1.51
Characteristics of black patients admitted to coronary care units in metropolitan Seattle: results from the Myocardial Infarction Triage and Intervention Registry (MITI). Am J Cardiol (1991) 1.51
Evidence for a novel pathway in the degradation of fluorene by Pseudomonas sp. strain F274. Appl Environ Microbiol (1994) 1.49
Dextrose and sorbitol as diluents for continuous intravenous heparin infusion. Br Med J (1972) 1.46
Beta adrenoceptor antagonists after myocardial infarction--where are we now? Br Heart J (1983) 1.45
Fluoride elimination from substrates in hydroxylation reactions catalyzed by p-hydroxybenzoate hydroxylase. J Biol Chem (1980) 1.41
Multiple microemboli after disintegration of clot during thrombolysis for acute myocardial infarction. BMJ (1989) 1.39
Purification and properties of a plasmid-encoded 2,4-dichlorophenol hydroxylase. FEBS Lett (1984) 1.38
Plasma concentrations of digoxin after oral administration in the fasting and postprandial ste. Br Med J (1971) 1.36
Isolation and characterization of (+)-1,1a-dihydroxy-1-hydrofluoren-9-one formed by angular dioxygenation in the bacterial catabolism of fluorene. Biochem Biophys Res Commun (1993) 1.34
The bimaxillary mouthguard: a preliminary report of use in contact sports. Aust Dent J (1986) 1.33
Use of an automated external defibrillator-pacemaker by ambulance staff. Lancet (1982) 1.33
Beta-adrenergic blockade in angina pectoris: a method of treadmill assessment. Br Med J (1966) 1.32
Effects of beta adrenergic blockade on heart size. Am J Cardiol (1966) 1.31
Amiodarone in the treatment of refractory supraventricular and ventricular arrhythmias. Postgrad Med J (1979) 1.31
Quality of life after coronary angioplasty or continued medical treatment for angina: three-year follow-up in the RITA-2 trial. Randomized Intervention Treatment of Angina. J Am Coll Cardiol (2000) 1.31
Catabolism of L-tyrosine by the homoprotocatechuate pathway in gram-positive bacteria. J Bacteriol (1976) 1.30
Performance characterization of a model bioreactor for the biodegradation of trichloroethylene by Pseudomonas cepacia G4. Appl Environ Microbiol (1991) 1.30
Mutants of Pseudomonas cepacia G4 defective in catabolism of aromatic compounds and trichloroethylene. Appl Environ Microbiol (1991) 1.26
Sequential atrioventricular pacing in heart block complicating acute myocardial infarction. N Engl J Med (1970) 1.25
Bilateral Upper Thoracic Sympathectomy in Angina Pectoris: Results in 52 Cases. Br Med J (1965) 1.25
The prevalence of orofacial injuries and use of mouthguards in Rugby Union. Aust Dent J (1985) 1.25
Metabolism of l-Malate and d-Malate by a Species of Pseudomonas. J Bacteriol (1970) 1.23
Degradation of protocatechuate in Pseudomonas testosteroni by a pathway involving oxidation of the product of meta-fission. J Bacteriol (1973) 1.23
Orofacial injuries and mouthguards: a study of the 1984 Wallabies. Br J Sports Med (1985) 1.23
Simple mechanical methods for cardioversion: defence of the precordial thump and cough version. Br Med J (Clin Res Ed) (1985) 1.22
Potassium depletion in severe heart disease. Br Med J (1969) 1.19
Comparison of haemodynamic responses to dopamine and salbutamol in severe cardiogenic shock complicating acute myocardial infarction. Br Med J (Clin Res Ed) (1981) 1.19
Policy for early discharge after acute myocardial infarction. Br Med J (1980) 1.19
Death in the clouds. Br Med J (Clin Res Ed) (1987) 1.18
Oxidation of naphthenoaromatic and methyl-substituted aromatic compounds by naphthalene 1,2-dioxygenase. Appl Environ Microbiol (1996) 1.15
Formation of indigo and related compounds from indolecarboxylic acids by aromatic acid-degrading bacteria: chromogenic reactions for cloning genes encoding dioxygenases that act on aromatic acids. J Bacteriol (1995) 1.15
The importance of the relationship between scale and process in understanding long-term DOC dynamics. Sci Total Environ (2010) 1.15
A method of assigning scores to the components of a composite outcome: an example from the MITI trial. Control Clin Trials (1992) 1.13
Digitalis: where are we now? Br Heart J (1985) 1.11
The location of collapse and its effect on survival from cardiac arrest. Ann Emerg Med (1987) 1.10
para-hydroxybenzoate as an intermediate in the anaerobic transformation of phenol to benzoate. FEMS Microbiol Lett (1991) 1.10
Purification and some properties of maleylpyruvate hydrolase and fumarylpyruvate hydrolase from Pseudomonas alcaligenes. J Bacteriol (1980) 1.09
Mobile coronary care provided by ambulance personnel. Br Heart J (1973) 1.09
Out-of-hospital resuscitation in East Sussex: 1981 to 1989. Br Heart J (1993) 1.08
Enzymatic release of halogens or methanol from some substituted protocatechuic acids. J Bacteriol (1985) 1.08
Atrial fibrillation complicating Wolff-Parkinson-White syndrome treated with amiodarone. Br Med J (1977) 1.06
Isolation and characterization of Escherichia coli mutants defective for phenylpropionate degradation. J Bacteriol (1986) 1.05